Fidelis Capital Partners, LLC Astrazeneca PLC Transaction History
Fidelis Capital Partners, LLC
- $1 Trillion
- Q4 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 2,916 shares of AZN stock, worth $222,228. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,916
Previous 17,491
83.33%
Holding current value
$222,228
Previous $1.35 Billion
84.86%
% of portfolio
0.02%
Previous 0.16%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.6 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.13 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.86 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.82 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.83 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $236B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...